Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A senior scientist at a large medical device company wanted to connect with Research & Development (R&D) engineers, scientists, clinicians, and chemists who focus on drug delivery or drug-eluting systems for implantable medical devices. This included antibacterial…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Marc Fischer, Co-Founder and CEO of Dogtown Media Brace yourselves for impact. Humanity is on the brink of a fourth industrial revolution thanks to machine learning. This subset of artificial intelligence (AI) is unlocking unprecedented value across every industry,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a major consulting firm was conducting due diligence for a private equity case on practice management IT solutions. They needed to speak with experts working in the industry, as well as IT decision-makers…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Hans Lagerweij, CEO and President of Victory Cruise Lines Expedition cruising is a fast-developing travel segment. Thirty-two new expedition ships are on order, with an estimated investment of over $4 billion. The big question is if the market growth...
Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a major consulting firm was conducting due diligence for a private equity case on practice management IT solutions. They needed to speak with experts working in the industry, as well as IT decision-makers…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Richard Saxon, Principal at Consultancy For The Built Environment If you are a building owner, you are probably missing out on the full advantages of going digital. Real Estate and Construction are laggard sectors in adopting technologies which can…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Ken Powell, President, Genesis Business Development The objective of companion diagnostics (CDx) is to maximize that a patient with a particular disease state has the highest probability of responding to a given therapeutic. CDx is now in its second…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Healthcare Analyst, Data Insights, Guidepoint Guidepoint’s Data Insights team is excited to announce that we have expanded Guidepoint Qsight’s data product offering to include models for Stryker (“SYK”) and Boston Scientific (“BSX”).   Prior to Stryker’s Q3…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Chris Slezakowski, Market Strategist HOW DO YOU KNOW WHEN YOUR BUSINESS NEEDS A BOOST? As businesses evolve, they need to convert or acquire new customers. The services or products provided operate in a complex system of multi-channel marketing, social…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Devin Craig, Owner and Principal of Craig Consulting Group How important is company culture? Can organizations perform well without a sense of “culture”? Recently a client asked me about this topic. He asked me, a little skeptically (maybe even…

Read More